Heterocyclic aromatic amine metabolism, DNA adduct formation, mutagenesis, and carcinogenesis

Drug Metabolism Reviews

Volumn 34, Issue 3, 2002, Pages 625-650

  Turesky, Robert J ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC AMINE; BIOLOGICAL MARKER; CARCINOGEN; HETEROCYCLIC AMINE; TOBACCO SMOKE; AMINE; DNA; HETEROCYCLIC COMPOUND; MUTAGENIC AGENT;

CHEMICAL CARCINOGENESIS; CHEMICAL MUTAGENESIS; CONFERENCE PAPER; COOKING; DNA ADDUCT; DNA BINDING; ENVIRONMENTAL EXPOSURE; FISH; FOOD CONTAMINATION; GENE MUTATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MEAT; NONHUMAN; POULTRY; TOBACCO; ANIMAL; BACTERIAL GENE; CHEMICAL STRUCTURE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; ONCOGENE; REVIEW; TUMOR SUPPRESSOR GENE;

AMINES; ANIMALS; CARCINOGENS; DNA; DNA ADDUCTS; GENE EXPRESSION REGULATION; GENES, BACTERIAL; GENES, TUMOR SUPPRESSOR; HETEROCYCLIC COMPOUNDS; HUMANS; MOLECULAR STRUCTURE; MUTAGENS; ONCOGENES;

EID: 0036041273     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-120005665     Document Type: Conference Paper

References (123)

1. Past, present, and future of mutagens in cooked foods
2. Contents in foods, beverages and tobacco
3. Heterocyclic amine mutagens/carcinogens in foods
4. High concentrations of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (phip) occur in chicken but are dependent on the cooking method
5. Detection of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in beer and wine
6. Detection of a carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, in cigarette smoke condensate
7. Formation of heterocyclic amines using model systems
8. Mutagen-carcinogens in food, with special reference to highly mutagenic pyrolytic products in broiled foods
9. Carcinogenic factors in food with relevance to colon cancer development
10. Overview of carcinogenic heterocyclic amines
11. Nutrition and colorectal cancer
12. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study amongst women
13. Diet, nutrition, and avoidable cancer
14. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps
15. The prostate: A target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods
16. Some perspectives on the nutritional aspects of breast cancer research. Food-derived heterocyclic amines as etiologic agents in human mammary cancer
17. Meat, fat and risk of breast cancer: A Case-control study from uruguay
18. Quantitative risk assessments of heterocyclic amines in cooked foods
19. Chemical carcinogens and overnutrition in diet-related cancer
20. How we should deal with unavoidable exposure of man to environmental mutagens: Cooked food mutagen discovery, facts and lessons for cancer prevention
21. Comparisons of catalytic selectivity of cytochrome P450 subfamily members from different species
22. Genetic polymorphisms
23. An overview of chemoprevention: Current status and future prospects
24. Inhibitory effect of bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen
25. Effects of human and rat glutathione-s-transferase on the covalent binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: A possible mechanism of organ specificity in their carcinogenesis
26. Protective properties of chlorophylls against the covalent binding of heterocyclic amines to DNA in vitro and in vivo
27. Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2
28. Pan-fried meat containing high levels of heterocyclic aromatic amines but low levels of polycyclic aromatic hydrocarbons induces cytochrome P4501A2 activity in Humans
29. DNA adducts of heterocyclic amine food mutagens implications for mutagenesis and carcinogenesis
30. In vivo metabolism of heterocyclic amines
31. Metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in human hepatocytes: 2-Amino-3-methylimidazo[4,5-f]quinoxaline-8-Carboxylic acid is a major detoxification pathway catalyzed by cytochrome P450 1A2
32. CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans
33. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1
34. The role of peroxidase-catalyzed activation of aromatic amines in breast cancer
35. Metabolic activation and covalent binding to nucleic acids of carcinogenic heterocyclic amines from cooked foods and amino acid pyrolysates
36. DNA adducts of heterocyclic aromatic amines arylazides and 4-nitroquinoline 1-oxide
37. Reaction of the N-hydroxylamine and N-acetoxy derivatives of 2-amino-3-methylimidazo[4,5-f]quinoline with DNA. Synthesis and identification of N-(Deoxyguanosin-8-yl)-IQ
38. 2-(2′-deoxyguanosin-8-yl)-PhIP
39. Induction of the base displacement or Z conformation in DNA by N-2-acetylaminofluorene modification
40. Formation and persistence of arylamine DNA adducts in vivo
41. DNA binding mutation spectra of the carcinogen N-2-aminofluorene in escherichia coli. A correlation between the conformation of the premutagenic lesion and the mutation specificity
42. Mutagenesis of the N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine DNA adduct in mammalian cells. Sequence context effects
43. DNA adduct-induced stabilization of slipped frameshift intermediates within repetitive sequences implications for mutagenesis
44. Carcinogen-induced frameshift mutagenesis in repetitive sequences
45. Solution structure of the 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine c8-deoxyguanosine adduct in duplex DNA
46. Characterization of DNA adducts formed in vitro by reaction of N-hydroxy2-amino-3-methylimidazo[4,5-f]quinoline and N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline at the C-8 and N2 atoms of guanine
47. Formation and persistence of DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline in the rat and nonhuman primates
48. Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential address
49. DNA adduct measurements tumor incidence during chronic carcinogen exposure in animal models implications for DNA adduct-based human cancer risk assessment
50. DNA adducts mutations and cancer
51. 32P-postlabeling assay
52. 32P-postlabeling assay
53. Enzymatic phase II activation of the N-hydroxylamines of IQ, MeIQx and PhIP by various organs of monkeys and rats
54. 2 atoms of guanine
55. 32P-post-labelling analysis of DNA adducts formed by food-derived heterocyclic amines: Evidence for incomplete hydrolysis and a procedure for adduct pattern simplification
56. Analysis and quantification DNA adducts of 2-amino-3,8-dimethylimidazo [4,5-f] quinoxaline in liver of rats by liquid chromatography/electrospray tandem mass spectrometry
57. DNA adduct formation of the food-derived mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates undergoing carcinogen bioassay
58. Human exposure to carcinogenic heterocyclic amines and their mutational fingerprints in animals
59. 32P-postlabeling
60. Accelerator mass spectrometry
61. Accelerator mass spectrometry in biomedical dosimetry: Relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA
62. MeIQx-DNA adduct formation in rodent and human tissues at low doses
63. Fate and distribution of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in mice at a human dietary equivalent dose
64. Covalent binding of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline to albumin and hemoglobin at environmentally relevant doses. Comparison of human subjects and F344 rats
65. DNA protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
66. High-performance liquid chromatography/electrospray mass spectrometry of the analysis of modified bases in DNA: 7-(2-hydroxyethyl)-guanine, the major ethylene oxide-DNA sequence adduct
67. Detection of in vivo formed DNA adducts at the part-per-billion level by capillary liquid chromatography/microelectrospray mass spectrometry
68. Quantification of the heterocyclic aromatic amine DNA adduct N-(deoxyguanosin-8-yl)-2-amino-3-methylimidazo[4,5-f]quinoline in livers of rats using capillary liquid chromatography/microelectrospray mass spectrometry: A dose-response study
69. Liquid chromatography/electron capture atmospheric pressure chemical ionization/mass spectrometry: Analysis of pentafluorobenzyl derivatives of biomolecules and drugs in the attomole range
70. 32P-postlabeling method, in the liver of rats fed MeIQx
71. Determination of in vitro formed DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine using capillary liquid chromatography/electrospray ionization/tandem mass spectrometry
72. 2(2′-deoxyguanosin-8-yl)PhIP adducts in DNA
73. Mutagens-carcinogens in foods
74. Mutagenic activity of heterocyclic amines in cooked foods
75. Base-change analysis of revertants of the hisD3052 allele in salmonella typhimurium
76. 6 to the mutagenic action of nitroarenes
77. Sensitive method for the detection of mutagenic nitroarenes and aromatic amines: New derivatives of salmonella typhimurium tester strains possessing elevated O-acetyltransferase levels
78. Mutational specificity of 2-nitro-3,4-dimethylimidazo[4,5-f]quinoline in the lacI gene of escherichia coli
79. Analysis of mutational specificity induced by heterocyclic amines in the lacZ gene of escherichia coli
80. Mutational and DNA binding specificity of the carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline
81. Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltransferase in escherichia coli
82. Recent advances in the construction of bacterial genotoxicity assays
83. Development of high sensitive umu test system: Rapid detection of genotoxicity of promutagenic aromatic amines by salmonella typhimurium strain NM2009 possessing high O-acetyltransferase activity
84. Metabolic activation of heterocyclic amines and other procarcinogens in salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase
85. Comparative genotoxic effects of the cooked-food-related mutagens Trp-P-2 and IQ in bacteria and cultured mammalian cells
86. Genotoxicity of compounds from cooked beef in repair-deficient CHO cells versus salmonella mutagenicity
87. Effect of heterocyclic amines and beef extract on chromosome aberrations and sister chromatid exchanges in cultured human lymphocytes
88. Induction of sister-chromatid exchanges by mutagens from amino acid and protein pyrolysates
89. Mammalian cell mutagenicity and metabolism of heterocyclic aromatic amines
90. Analysis of mutations induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in human lymphoblastoid cells
91. Mutation and repair induced by the carcinogen 2-(hydroxyamino)-1-methyl-6-phenylimidazo [4,5-b]pyridine (N-OH-PhIP) in the dihydrofolate reductase gene of chinese hamster ovary cells and conformational modeling of the dG-C8-PhIP adduct in DNA
92. Identification of Aprt gene mutations induced in repair-deficient and P450-expressing CHO cells by the food-related mutagen/carcinogen, PhIP
93. Mutational spectra of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) at the chinese hamsters hprt locus
94. Specific 5′-GGGA-3′ ↔ 5′-GGA-3′ mutation of the APC gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
95. Mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in human lymphoblastoid cells
96. Genetic changes induced by heterocyclic amines
97. Carcinogenic factors in food with relevance to colon cancer development
98. p53 gene mutation in hepatocellular carcinoma induced by 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates
99. APC mutations occur early during colorectal tumorigenesis
100. Early detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine(PhIP)-induced mutations within the Apc gene of rat colon
101. High frequency of beta-catenin (ctnnbl) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat
102. Mammary gland
103. Infrequent mutation of Ha-ras and p53 in rat mammary carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
104. Agreement of mutational characteristics of heterocyclic amines in lacI of the big blue mouse with those in tumor related genes in rodents
105. Effects of gender and species on spectra of mutation induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the lacI transgene
106. Preferential induction of guanine deletion at 5′-GGGA-3′ in rat mammary glands by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
107. Prostate mutations in rats induced by the suspected human carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
108. LacI transgenic animal study: Relationships among DNA-adduct levels, mutant frequencies and cancer incidences
109. Mutational analysis of the liver, colon and kidney of big blue rats treated with 2-amino-3-methylimidazo[4,5-f]quinoline
110. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine is a potent mutagen in the mouse small intestine
111. + allele
112. In vivo mutagenicity and DNA adduct levels of heterocyclic amines in muta mice and c-myc/lacZ double transgenic mice
113. Transgenic mouse models in carcinogenesis research and testing
114. Analysis of synergism in hepatocarcinogenesis based on preneoplastic foci induction by 10 heterocyclic amines in the rat
115. Synergistic enhancement of small and large intestinal carcinogenesis by combined treatment of rats with five heterocyclic amines in a medium-term multi-organ bioassay
116. Carcinogenicity in animals and specific organs
117. Metabolism of food-derived heterocyclic amines in nonhuman primates
118. Protein adducts in the molecular dosimetry of chemical carcinnnnogens